Detection of the Activation of Nuclear Factor Kappa Βeta NF-KB Signalization Pathway in Peripheral Giant Cell Granulomas

Yıl 2011, Cilt: 5 Sayı: 3, 973 - 978, 01.10.2011

Ömür Dereci

Öz

The aim of this study is to detect the activity of NF-KB signalization system in peripheral giant cell granulomas in order to determine the origin of the pathogenesis of the lesion. The clinical data and paraffin blocks of twenty nine cases of peripheral giant cell granuloma were retrieved from the archives. Glass slides were prepared from retrieved paraffin blocks and subsequently immunostained with NF-KB antibody. 97 % of the selected cases were highly or moderadetly stained with NF-KB immunostaining. All cases showed reactivity with NF-KB immunostain. The detection of the activation of NF-KB pathway in peripheral giant cell granulomas suggest that these lesions may have an inflammatory origin. In future studies, modification of NF-KB pathway with drugs may reduce the growth potential or prevent the occurrence of the peripheral giant cell granuloma

Anahtar Kelimeler

Peripheral giant cell granuloma, giant cell, osteoclast like giant cell, nuclear factor kappa beta

Periferal Dev Hücreli Granülomalarda Nükleer Faktör Kappa Beta NF-KB Sinyal Yolağının Aktivitesinin Araştırılması

Öz

İnflamatuar gen anlatımında çok büyük rolü olan nükleer faktör kappa beta NF-KB sinyal sisteminin periferal dev hücreli granülomalarda aktif olup olmadığını araştırmak, böylece bu lezyonların oluşumlarının inflamatuar bir patogenezden köken alıp almadığı konusunda fikir sahibi olabilmektir. Retrospektif olarak elde edilmiş 29 vakanın klinik bilgileri incelenip, parafin bloklardan elde edilen yeni kesitler üzerinde immunohistokimyasal NF-KB boyaması yapıldı. Tüm vakaların % 97’sinde şiddetli ve orta şiddetli boyanma tespit edildi. Bütün vakalarda NF-KB aktivasyonu gözlendi. NF-KB sinyal yolağının periferal dev hücreli lezyonlarda aktif olması bu lezyonların inflamatuar kökenli patolojiler olduğunu göstermektedir. Gelecek çalışmalarda NF-KB sinyal sisteminin ilaçlarla modifiye edilmesi ile bu lezyonlara karşı durdurucu tedavi stratejileri geliştirilebilir

Anahtar Kelimeler

Perifereral dev hücreli granüloma, dev hücre, osteoklast tipi dev hücre, nükleer faktör kappa beta

Kaynakça

• Jaffe, H.L. Giant cell reparative granuloma, trau- matic bone cyst and fibrous (fibro-osseous) dyspla- sia of jawbones. J. Oral Surg. 6: 159-175,1953
• Cawson R.A., Eveson J.W. Oral Pathology and Di- agnosis. London: William Heinemann Medical Bo- oks, 1987
• Nedir R, Lombardi T, Samson J. Recurrent periphe- ral giant cell granuloma associated with cervical resorption. J. Periodontol. 68:381-384, 1997
• Ghosh S, May Mj, Kopp Eb. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol.16:225- 260, 1998
• Sen R, Baltimore D.Inducibility of kappa immunog- lobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell. 47:921-928, 1986
• Baldwin As Jr. The NF-kappa B and I kappa B pro- teins: new discoveries and insights. Annu. Rev. Immunol.14:649-683, 1996
• Gupta Sc, Sundaram C, Reuter S, Aggarwal BB. Inhibiting NF-B activation by small molecu- les as a therapeutic strategy. Biochim. Biophys. Acta.1799:775-787, 2010
• Katsikeris N, Kakarantza-Angelopoulou E, Angelo- poulos AP. Peripheral giant cell granuloma. Cli- nicopathologic study of 224 new cases and revi- ew of 956 reported cases. Int. J. Oral Maxillofac. Surg. 17:94-99, 1988
• Günhan, Ö. Oral ve Maksillofasiyal Patoloji. 1. Bas- kı. Ankara: Atlas kitapçılık, 2001
• Richmond A. Nf-kappa B, chemokine gene trans- cription and tumour growth. Nat. Rev. Immunol. 2:664-674, 2002
• Baldwin As Jr. Series introduction: the transcription factor NF-kappaB and human disease. J. Clin. In- vest. 107:3-6, 2001
• Katsikeris N, Kakarantza-Angelopoulou E, Ange- lopoulos AP. Peripheral giant cell granuloma. Cli- nicopathologic study of 224 new cases and revi- ew of 956 reported cases. Int. J. Oral Maxillofac. Surg.17:94-99, 1988
• Torabinia N, Razavi SM, Shokrolahi Z. A com- parative immunohistochemical evaluation of CD68 and TRAP protein expression in central and perip- heral giant cell granulomas of the jaws. J. Oral Pathol. Med. 40:334-337, 2011
• Bonetti F., Pelosi G., Martignoni G., Mombello A., Zamboni G., Pea M., Scarpa A., Chilosi M. Pe- ripheral giant cell granuloma: evidence for oste- oclastic differentiation. Oral Surg. Oral Med. Oral Pathol. 70:471-475, 1990
• Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Ben- nett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 89:309-319, 1997
• Gupta SC, Sundaram C, Reuter S, Aggarwal BB. Inhibiting NF-B activation by small molecules as a therapeutic strategy. Biochim. Biophys. Acta. 1799:775-787, 2010
• Fanourakis G, Krithinakis S, Tosios KI, Sklavounou A, Tseleni-Balafouta S. Expression of receptor ac- tivator of NF-B ligand and osteoprotegerin in pe- ripheral giant cell granulomas of the jaws. J. Oral Pathol. Med. 39:687-689, 2010